500-Bedded Odisha COVID-19 Hospital Becomes Operational in KIMS

Bhubaneswar: A 500-Bedded Odisha COVID-19 Hospital managed and run by Kalinga Institute of Medical Sciences (KIMS), Bhubaneswar has become operational from 2nd April 2020.

Govt. of Odisha is financing equipment and operational costs through CSR policy of OMC. Naveen Patnaik, Hon’ble Chief Minister of Odisha declared the hospital operational in the presence of Dr. Achyuta Samanta, Founder, KIIT & KISS; Dr. Subrat Acharya, Pro-Chancellor, KIIT Deemed to University and Dr. Bishnu Prasad Panigrahi, CEO, KIMS today.

The Odisha COVID Hospital has 500-bed infrastructure, including 50 critical care beds. It is well-equipped with latest instruments and other facilities. The Odisha COVID Hospital is functioning from a dedicated block of KIMS having a dedicated and exclusive team of doctors, nurses, paramedics and housekeeping staff. COVID suspects as well COVID patients will have a separate entrance and exit to KIMS campus and not intermingle with non COVID patients. The Hospital has no linkage with other departments of KIMS and is led by Dr. Bishnu Prasad Panigrahi under the guidance of Dr. Subrat Acharya.

“The Hospital adheres to the standard best practices and follows WHO and ICMR guidelines. It will be functional round the clock”, informed Dr. A. Samanta.

Related Posts

Moonshot, SS Innovations displayed Battle Readiness for Monumental Goals in Robotic Surgery

Bharat Mandapam witnessed Spectacle of Crazy Innovations by Maker of Ssi Mantra, Best in class Surgical Robot New Delhi: It was a veritable display of innovative potential and prowess of…

On World Health Day ‘CAHO Na Patient Se Pyaar Hai’

Chennai hosts 3 Day International Conference CAHOCON on Patient Safety in Hospitals starting April 10 New Delhi:  Patient safety in hospitals is a global concern, more so in India. It…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Delhi Crime Branch Seizes Huge Stock Of Expired Baby Food, Cosmetics; One Arrested

Delhi Crime Branch Seizes Huge Stock Of Expired Baby Food, Cosmetics; One Arrested

FDA Releases Draft Guidance To Validate Non-Animal Testing Methods (NAMs) In Drug Development

FDA Releases Draft Guidance To Validate Non-Animal Testing Methods (NAMs) In Drug Development

IPC releases draft NFI-2026 to promote rational use of medicines

IPC releases draft NFI-2026 to promote rational use of medicines

Moonshot, SS Innovations displayed Battle Readiness for Monumental Goals in Robotic Surgery

Moonshot, SS Innovations displayed Battle Readiness for Monumental Goals in Robotic Surgery

US market to dent India pharma earnings even as domestic growth remains firm

US market to dent India pharma earnings even as domestic growth remains firm

Biocon Pharma receives USFDA approval for Dapagliflozin Tablets, 5 mg and 10 mg

Biocon Pharma receives USFDA approval for Dapagliflozin Tablets, 5 mg and 10 mg